Related Experiment Videos

Rheolytic catheter for percutaneous removal of thrombus

W J Drasler1, M L Jenson, G J Wilson

  • 1Possis Medical, Minneapolis, MN 55427.

Radiology
|January 1, 1992
PubMed

Insights

A novel rheolytic thrombectomy catheter (RTC) uses high-velocity saline jets to effectively dissolve and remove blood clots. This percutaneous system shows promise for treating vascular occlusions in various vessel sizes.

Area of Science:

  • Biomedical Engineering
  • Vascular Surgery
  • Interventional Radiology

Background:

  • Thrombus formation poses significant risks, necessitating effective removal methods.
  • Current treatments like thrombolysis can be slow and may not be suitable for all cases.
  • Percutaneous approaches offer less invasive alternatives for clot removal.

Purpose of the Study:

  • To introduce and evaluate a novel percutaneous thrombectomy system utilizing rheolytic technology.
  • To assess the efficacy and safety of the rheolytic thrombectomy catheter (RTC) in clot lysis and removal.

Main Methods:

  • Development of a rheolytic thrombectomy catheter (4-6 F) designed to deliver high-velocity saline jets.
  • In vitro testing using whole blood clots in simulated vascular tubing (6-9 mm diameter).
  • In vivo evaluation in a canine femoral artery model to assess clot removal and vessel integrity.

Main Results:

  • Complete dissolution and removal of 10-15 cm blood clots in vitro within 1 minute.
  • Successful lysis and removal of clots from a canine femoral artery in vivo.
  • No observed vessel damage during in vivo experiments.

Conclusions:

  • The rheolytic thrombectomy catheter (RTC) demonstrates high efficacy in rapid clot lysis and removal.
  • The system's design (small caliber, flexibility) suggests potential for treating diverse vascular occlusions.
  • RTC offers a promising percutaneous alternative for managing thrombus in challenging anatomical locations.

Related Concept Videos